Literature DB >> 2218891

Long-term results of surgical resection of locally advanced colorectal carcinoma.

S B Eisenberg1, W G Kraybill, M J Lopez.   

Abstract

This study was undertaken to review the long-term results of multivisceral resection of locally advanced colorectal carcinoma. Between 1964 and 1980, 1042 patients underwent exploratory surgery for colorectal cancer. Of these, 58 patients (5.5%) underwent curative multivisceral resection for suspected contiguous invasion by the primary tumor. Follow-up was complete for all patients. The primary tumors were located in the rectum (38 patients), sigmoid (9 patients), left colon (6 patients), and right colon (5 patients). En bloc resection of other viscera included uterus, adnexa, bladder, vagina, small intestine, abdominal wall, liver, stomach, kidney, and ureter. The operative morbidity and mortality rates were 31% and 1.7%, respectively. Resection margins were free of tumor in 54 patients. In the four patients with tumor-positive resection margins, recurrence of disease was evident between 8 and 22 weeks after surgery (mean survival time, 8.2 months). Carcinomatous invasion of the resected contiguous organ was confirmed in 49 patients (84%). The mean survival time for patients without lymph node metastases was 100.7 months, but it was only 16.2 months (p less than 0.01) for patients with lymph node metastases. Actuarial 5-year disease-free survival rate for patients without lymph node metastases was 76% (36 of 47 patients). None of the patients (0 of 11) with lymph node metastases survived for 5 years. Three of 36 of the 5-year survivors experienced recurrence of disease before the seventh postoperative year; no cancer-related deaths occurred between 7 and 25 years. These data suggest that survival in locally advanced colorectal carcinoma is more dependent on lymph node status than on the extent of local invasion. Effective disease control associated with survival in the long term can be achieved by multivisceral resection.

Entities:  

Mesh:

Year:  1990        PMID: 2218891

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  21 in total

1.  Surgical resection of locally advanced primary transverse colon cancer--not a worse outcome in stage II tumor.

Authors:  Hsin-Yuan Hung; Chien-Yuh Yeh; Chung-Rong Changchien; Jinn-Shiun Chen; Chung-Wei Fan; Reiping Tang; Pao-Shiu Hsieh; Wen-Sy Tasi; Yau-Tong You; Jeng-Fu You; Jeng-Yi Wang; Jy-Ming Chiang
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

2.  Transureteroureterostomy allows renal sparing radical resection of advanced malignancies with rectosigmoid invasion.

Authors:  Sven Richter; Otto Kollmar; Werner Lindemann; Martin K Schilling
Journal:  Int J Colorectal Dis       Date:  2006-11-21       Impact factor: 2.571

3.  Curative surgery improves the survival of patients with perforating colorectal cancer.

Authors:  Kotaro Shibahara; Hiroyuki Orita; Tadashi Koga; Hitoshi Kohno; Hisanobu Sakata; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

4.  [Multivisceral resection of advanced colorectal cancer].

Authors:  K H Schultheis; S Ruckriegel; C Gebhardt
Journal:  Langenbecks Arch Chir       Date:  1994

Review 5.  Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.

Authors:  Rathin Gosavi; Clemente Chia; Michael Michael; Alexander G Heriot; Satish K Warrier; Joseph C Kong
Journal:  Int J Colorectal Dis       Date:  2021-05-04       Impact factor: 2.571

6.  Outcome of surgical management of the bladder in advanced colorectal cancer.

Authors:  Feng Gao; Yun-fei Cao; Li-sheng Chen; Sen Zhang; Zong-jiang Tang; Jun-lin Liang
Journal:  Int J Colorectal Dis       Date:  2006-03-01       Impact factor: 2.571

7.  Analysis of the prognostic effectiveness of a multivisceral resection for locally advanced colorectal cancer.

Authors:  Sejin Park; Yun Sik Lee
Journal:  J Korean Soc Coloproctol       Date:  2011-02-28

Review 8.  Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion?

Authors:  A B Delaloye; B Delaloye
Journal:  Eur J Nucl Med       Date:  1995-06

9.  Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade.

Authors:  Michael J Overman; Keith Fournier; Chung-Yuan Hu; Cathy Eng; Melissa Taggart; Richard Royal; Paul Mansfield; George J Chang
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

10.  Management of patients with carcinoma of the right colon invading the duodenum or pancreatic head.

Authors:  David Fuks; Patrick Pessaux; Jean-Jacques Tuech; François Mauvais; Olivier Bréhant; Frédéric Dumont; Denis Chatelain; Thierry Yzet; Jean-Paul Joly; Benoit Lefebure; Sushil Deshpande; Jean-Pierre Arnaud; Pierre Verhaeghe; Jean-Marc Regimbeau
Journal:  Int J Colorectal Dis       Date:  2008-01-24       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.